Evidence map›Paper›PMID 33558557›Full record

ArticleScientific reports2021

Mutational processes in cancer preferentially affect binding of particular transcription factors.

Mo Liu, Arnoud Boot, Alvin W T Ng, Raluca Gordân, Steven G Rozen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Multisite λ-Dynamics for Protein-DNA Binding Affinity Prediction.Journal of chemical theory and computation · 2025
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mo LiuProgramme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
Arnoud BootProgramme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
Alvin W T NgProgramme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
Raluca GordânDepartment of Biostatistics and Bioinformatics, Center for Genomic and Computational Biology, Duke University, Durham, NC, USA.
Steven G RozenProgramme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore. steve.rozen@duke-nus.edu.sg.
Duke-NUS Medical School · SGDuke University · US

Funding

New methods for quantitative modeling of protein-DNA interactionsR01GM117106 · NIGMS · DUKE UNIVERSITY · PI GORDAN, RALUCA · 2015 to 2019
$1.8M
NIGMS NIH HHS R01 GM117106
6 · The paper itself

Abstract

Protein binding microarrays provide comprehensive information about the DNA binding specificities of transcription factors (TFs), and can be used to quantitatively predict the effects of DNA sequence variation on TF binding. There has also been substantial progress in dissecting the patterns of mutations, i.e., the "mutational signatures", generated by different mutational processes. By combining these two layers of information we can investigate whether certain mutational processes tend to preferentially affect binding of particular classes of TFs. Such preferential alterations of binding might predispose to particular oncogenic pathways. We developed and implemented a method, termed "Signature-QBiC", that integrates protein binding microarray data with the signatures of mutational processes, with the aim of predicting which TFs' binding profiles are preferentially perturbed by particular mutational processes. We used Signature-QBiC to predict the effects of 47 signatures of mutational processes on 582 human TFs. Pathway analysis showed that binding of TFs involved in NOTCH1 signaling is strongly affected by the signatures of several mutational processes, including exposure to ultraviolet radiation. Additionally, toll-like-receptor signaling pathways are also vulnerable to disruption by this exposure. This study provides a novel overview of the effects of mutational processes on TF binding and the potential of these processes to activate oncogenic pathways through mutating TF binding sites.

Indexed as

CarcinogenesisModels, BiologicalNeoplasm ProteinsNeoplasmsResponse ElementsTranscription FactorsHumansMutationNeoplasm ProteinsTranscription Factors

Identifiers

PMID33558557
PMCPMC7870974
OpenAlexW3128498209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.